SEC filing · 8-K

Achieve Life Sciences, Inc.: Executive or director change

Achieve Life Sciences appointed Benjamin Halladay as Chief Financial Officer effective October 5, 2026, succeeding Mark Oki.

Filed October 1, 2026

Neutral news

What happened

Achieve Life Sciences appointed Benjamin Halladay as Chief Financial Officer and principal financial officer effective October 5, 2026.

The full interpretation is in the app

Why it matters, the key numbers from the document and what to watch next: the full interpretation of every report is part of Pro.

Read the full interpretation

Read the original

Filing document on SEC.gov All documents of this filing

Back to Achieve Life Sciences, Inc.

Summary generated automatically from the filing text and checked against it: every number above is printed in the document. It describes the filing and is not investment advice. Read the original before relying on it.